202 related articles for article (PubMed ID: 23948416)
1. [Expressions and clinical significance of OX40 and OX40L in peripheral blood of patients with primary Sjogren's syndrome].
Zhu R; Jiang J; Wang T; Xu T; Wu M; Liu C; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):862-5. PubMed ID: 23948416
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis.
Zhou X; Wang X; Gu Y; Chen L; Shen Y; Tian J; Shujun C; Wang M; Duan X; Gao H; Ji X; Fang Q; Zhang X; Xue Q
J Immunol Res; 2022; 2022():4337399. PubMed ID: 35265719
[TBL] [Abstract][Full Text] [Related]
4. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
[TBL] [Abstract][Full Text] [Related]
5. Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia.
Cui D; Lv Y; Yuan X; Ruan G; Zhang Y; Yan C; Xu D; Lv M; Mao Y; Cao J; Jin J; Xie J
J Immunol Res; 2019; 2019():6804806. PubMed ID: 30944836
[TBL] [Abstract][Full Text] [Related]
6. OX40 mRNA in peripheral blood as a biomarker of acute renal allograft rejection.
Wang YL; Fu YX; Zhu ZJ; Wang H; Shen ZY
Chin Med J (Engl); 2012 Nov; 125(21):3786-90. PubMed ID: 23106874
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction.
Liu B; Yu G; Yang Z; Sun L; Song R; Liu F; Xin Y; Zhang L
J Int Med Res; 2009; 37(3):601-10. PubMed ID: 19589242
[TBL] [Abstract][Full Text] [Related]
8. miR-146a and miR-155 expression in PBMCs from patients with Sjögren's syndrome.
Shi H; Zheng LY; Zhang P; Yu CQ
J Oral Pathol Med; 2014 Nov; 43(10):792-7. PubMed ID: 24931100
[TBL] [Abstract][Full Text] [Related]
9. Kawasaki disease OX40-OX40L axis acts as an upstream regulator of NFAT signaling pathway.
Lv YW; Chen Y; Lv HT; Li X; Tang YJ; Qian WG; Xu QQ; Sun L; Qian GH; Ding YY
Pediatr Res; 2019 May; 85(6):835-840. PubMed ID: 30723312
[TBL] [Abstract][Full Text] [Related]
10. Activity of T-helper cells in patients with primary Sjogren's syndrome.
Sudzius G; Mieliauskaite D; Butrimiene I; Siaurys A; Mackiewicz Z; Dumalakiene I
In Vivo; 2013; 27(2):263-8. PubMed ID: 23422488
[TBL] [Abstract][Full Text] [Related]
11. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.
Li X; Li X; Qian L; Wang G; Zhang H; Wang X; Chen K; Zhai Z; Li Q; Wang Y; Harris DC
J Rheumatol; 2007 Dec; 34(12):2438-45. PubMed ID: 18050367
[TBL] [Abstract][Full Text] [Related]
12. Influence of total glucosides of paeony on PD-1/PD-L1 expression in primary Sjögren's syndrome.
Chen Y; Wang Y; Xu L; Zhu W; Xu C; Xu M; Guo L; Hu W; Xu D; Jing R; Zhu Y; He J; Xu B
Int J Rheum Dis; 2019 Feb; 22(2):200-206. PubMed ID: 30338648
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
[TBL] [Abstract][Full Text] [Related]
14. The expression of P2X7 receptors on peripheral blood mononuclear cells in patients with primary Sjögren's syndrome and its correlation with anxiety and depression.
Xie B; Chen Y; Zhang S; Wu X; Zhang Z; Peng Y; Huang X
Clin Exp Rheumatol; 2014; 32(3):354-60. PubMed ID: 24480517
[TBL] [Abstract][Full Text] [Related]
15. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
16. Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome.
Zheng L; Zhang Z; Yu C; Yang C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):844-50. PubMed ID: 20399690
[TBL] [Abstract][Full Text] [Related]
17. Relative Expression of OX40, OX40L mRNA, and OX40L Serum Levels in Women with Recurrent Spontaneous Abortion.
Rahmani F; Hadinedoushan H; Ghasemi N
Immunol Invest; 2019 Jul; 48(5):480-489. PubMed ID: 30794011
[TBL] [Abstract][Full Text] [Related]
18. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
19. IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.
Alunno A; Bistoni O; Bartoloni Bocci E; Caterbi S; Bigerna B; Pucciarini A; Tabarrini A; Mannucci R; Beghelli D; Falini B; Gerli R
Reumatismo; 2013 Oct; 65(4):192-8. PubMed ID: 24192564
[TBL] [Abstract][Full Text] [Related]
20. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome.
Liu MF; Lin LH; Weng CT; Weng MY
Lupus; 2008 Jan; 17(1):34-9. PubMed ID: 18089681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
